|
TADA2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.067800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.793400E-01 |
| Normal-vs-Stage2 |
4.557600E-01 |
| Normal-vs-Stage3 |
3.519600E-02 |
| Normal-vs-Stage4 |
9.202100E-02 |
| Stage1-vs-Stage2 |
4.900000E-01 |
| Stage1-vs-Stage3 |
2.785700E-02 |
| Stage1-vs-Stage4 |
9.228400E-02 |
| Stage2-vs-Stage3 |
4.243400E-01 |
| Stage2-vs-Stage4 |
5.639600E-01 |
| Stage3-vs-Stage4 |
8.306000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.119160E-01 |
| Normal-vs-AfricanAmerican |
6.493200E-01 |
| Normal-vs-Asian |
5.041600E-02 |
| Caucasian-vs-AfricanAmerican |
5.621000E-01 |
| Caucasian-vs-Asian |
2.224200E-04 |
| AfricanAmerican-vs-Asian |
2.818700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.945900E-02 |
| Normal-vs-Female |
7.055400E-01 |
| Male-vs-Female |
5.960900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.314600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.749400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.138420E-01 |
| Normal-vs-Age(81-100Yrs) |
4.644200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.758400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.505600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.885600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.429800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.844400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.942530E-03 |
| Normal-vs-Grade 2 |
6.879000E-01 |
| Normal-vs-Grade 3 |
9.476800E-03 |
| Normal-vs-Grade 4 |
2.408100E-02 |
| Grade 1-vs-Grade 2 |
2.336200E-02 |
| Grade 1-vs-Grade 3 |
1.567220E-04 |
| Grade 1-vs-Grade 4 |
6.816700E-04 |
| Grade 2-vs-Grade 3 |
6.969200E-04 |
| Grade 2-vs-Grade 4 |
6.820300E-03 |
| Grade 3-vs-Grade 4 |
6.890600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.175400E-01 |
| Normal-vs-ccB subtype |
3.720600E-03 |
| ccA subtype-vs-ccB subtype |
2.25890000005169E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.997200E-01 |
| Normal-vs-N1 |
3.045600E-01 |
| N0-vs-N1 |
6.948600E-01 |
|
|
